Neurocrine Biosciences (NBIX) EPS US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | 0.95 | 1.61 | 2.56 | 3.40 | 4.81 | 6.65 | ||
| Changes by years, y/y, % | -78% | +70% | +58% | +33% | +41% | +1.9% | |||
Neurocrine Biosciences. EPS, rub
Neurocrine Biosciences. EPS, changes, %
Neurocrine Biosciences (NBIX) EPS US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EPS, rub | ? | 0.08 | 1.09 | 2.11 | 1.54 | 1.97 | 6.65 | |
| Changes by years, y/y, % | -82% | +68% | +64% | +50% | +2 385% | |||
| Changes by quarters, q/q, % | -92% | +1 270% | +94% | -27% | +27% | |||